New ultrasound and DNA test could revolutionize leprosy diagnosis

NCT ID NCT07515989

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a new approach—using ultrasound to guide a tiny needle to collect fluid near the ulnar nerve, then analyzing it for leprosy bacteria DNA—can more accurately diagnose leprosy and confirm when it's cured. Researchers will follow 108 participants for one year, comparing this method to standard tests. If it works, it could lead to earlier treatment and fewer long-term disabilities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ultrasound-guided perineural subcutaneous aspirate with PCR analysis
What this could lead to
If successful, this could provide a more accurate way to diagnose leprosy early and confirm when the disease is cured, potentially reducing nerve damage and disability.
What could go wrong
This is a small, early-stage study (108 participants) testing a new diagnostic method. The technique may not prove more accurate than existing tests, and results may not apply to all leprosy patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPROSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital of Brasília

    RECRUITING

    Brasília, Federal District, 70.830-200, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.